Literature DB >> 8176923

Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer.

M Maeta1, N Shimizu, A Oka, A Kondo, H Yamashiro, S Tsujitani, M Ikegchi, N Kaibara.   

Abstract

The immunomodulative effect of perioperative allogeneic blood transfusion on host immunocompetence was studied in 109 patients with gastric cancer at various stages. Mitogen-induced lymphocyte blastogenesis, lymphocyte surface markers (specific for T, B, CD4, and CD8 populations), and the activity of natural killer (NK) cells were examined before surgery and then 2 and 4 weeks after surgery. The effects on host immunocompetence of transfusion alone, in the absence of any effect of surgical stress, were studied, preoperatively, in nine patients who received preoperative transfusion. Although a tendency towards a decrease in the posttransfusion activity of NK cells was observed, there were no statistically significant differences between pre- and posttransfusion levels. Mitogen-induced blastogenesis and the activity of NK cells were significantly impaired 2 weeks after surgery in transfused patients as compared to those in nontransfused patients with gastric cancer at stage III and stage IV, and postoperative survival was significantly lower in transfused as compared to nontransfused patients. These results indicate that perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer.

Entities:  

Mesh:

Year:  1994        PMID: 8176923     DOI: 10.1002/jso.2930550304

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  15 in total

1.  Impact of intraoperative blood loss on survival after curative resection for gastric cancer.

Authors:  Yue-Xiang Liang; Han-Han Guo; Jing-Yu Deng; Bao-Gui Wang; Xue-Wei Ding; Xiao-Na Wang; Li Zhang; Han Liang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy.

Authors:  Toshiyasu Ojima; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Teiji Naka; Masahiro Katsuda; Takeshi Iida; Keiji Hayata; Hiroki Yamaue
Journal:  J Gastrointest Surg       Date:  2009-08-05       Impact factor: 3.452

3.  Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.

Authors:  Mitsuro Kanda; Daisuke Kobayashi; Chie Tanaka; Naoki Iwata; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Shuji Nomoto; Kenta Murotani; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2015-01-07       Impact factor: 7.370

4.  The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database.

Authors:  Maryam Elmi; Alyson Mahar; Daniel Kagedan; Calvin H L Law; Paul J Karanicolas; Yulia Lin; Jeannie Callum; Natalie G Coburn; Julie Hallet
Journal:  Can J Surg       Date:  2016-09       Impact factor: 2.089

5.  A tailored perioperative blood transfusion might avoid undue recurrences in gastric carcinoma patients.

Authors:  D K Dhar; H Kubota; M Tachibana; T Kotoh; S Kinugasa; M Shibakita; H Kohno; N Nagasue
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

6.  Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N'-nitro-N-nitrosoguanidine-enduced gastric cancer rats.

Authors:  Cong Luo; Xian-Guo Wu
Journal:  Int J Mol Sci       Date:  2011-05-23       Impact factor: 5.923

7.  Does perioperative blood transfusion influence long-term prognosis of gastric cancer?

Authors:  F Sánchez-Bueno; J A García-Marcilla; J M Pérez-Abad; R Vicente; F Aranda; J A Lujan; P Parrilla
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

8.  SPan-1 is a useful prognostic marker for patients with stage IV gastric cancer who underwent palliative gastrectomy: a retrospective multivariate study.

Authors:  Naoshi Kubo; Masaichi Ohira; Katsunobu Sakurai; Takahiro Toyokawa; Hiroaki Tanaka; Kazuya Muguruma; Hisashi Nagahara; Kenjiro Kimura; Eiji Noda; Ryosuke Amano; Nobuya Yamada; Masakazu Yashiro; Kiyoshi Maeda; Tetsuji Sawada; Kosei Hirakawa
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

9.  Transfusion alert for patients with curable cancer.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Shiroh Kikuchi; Natsuya Katada; Nobuyuki Kobayashi; Masahiko Watanabe
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.282

10.  Perioperative Allogenenic Blood Transfusion is Associated With Worse Clinical Outcome for Patients Undergoing Gastric Carcinoma Surgery: A Meta-Analysis.

Authors:  Lihong Li; Dajian Zhu; Xiaowu Chen; Yanfeng Huang; Manzhao Ouyang; Weijie Zhang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.